S2-E25.2 (CORRECTED) - Prevalence of NAFLD and NASH 2021 -- Deeper Dive
Send us a text (This episode has been reposted to include the complete conversation content.) Louise Campbell and Roger Green join co-authors Stephen Harrison, Naim Alkhouri and first-time guest Prof. Samer Gowrieh to dive deeper into key findings from the 2021 Journal of Hepatology paper titled "Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort." A deeper dive into the data coming from the 2021 Journal of He...
17 Maj 202114min
S2-E25.3 (CORRECTED) - Prevalence of NAFLD and NASH 2021 -- An Urgent Call to Action
Send us a text (This episode has been reposted to include the complete conversation content.) Louise Campbell and Roger Green join co-authors Stephen Harrison, Naim Alkhouri and first-time guest Prof. Samer Gowrieh to discuss why this epidemiology paper from the 2021 Journal of Hepatology is an urgent call to action on NAFLD and NASH screening and treatment. Considered in its totality, the data emerging from the 2021 Journal of Hepatology paper "Prospective evaluation of the prevalen...
17 Maj 202120min
S2-E25 - How many Americans Are Living with NAFLD and NASH?
Send us a text Study co-authors Stephen Harrison, Naim Alkhouri and Samer Gawrieh suggest that current estimates of NAFLD and NASH populations in the US may be meaningfully understated. Earlier this year, Drs. Harrison, Alkhouri, Gawrieh and seven co-authored published a paper in the Journal of Hepatology titled, "Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort." This study of 664 non-symptomatic patients reve...
13 Maj 202154min
S2-E24.3 - From The Fourth Global NASH Congress -- How Diagnostics Will Evolve Over The Next Several Years
Send us a text After having time to think, six of the panelists who covered sessions at the Fourth Global NASH Congress get together one more time to conisder key takeaways from the Congress. This conversation is organized around competing strategies for diagnostic testing as the NASH market evolves. After hearing presentations from 43 speakers at the Fourth Global NASH Congress, six SurfingNASH panelists convene once more to debate how the diagnostics market will develop. With a profusion o...
9 Maj 202115min
S2-E24.2 - From The Fourth Global NASH Congress -- How Treatment WIll Evolve Over The Next Several Years
Send us a text After having time to think, six of the panelists who covered sessions at the Fourth Global NASH Congress get together one more time to consider key takeaways from the Congress. This conversation is organized around adoption of non-invasive testing in clinical development and when drugs will come to market. After hearing presentations from 43 speakers at the Fourth Global NASH Congress, six SurfingNASH panelists convene once more to debate how long it will take before we have n...
8 Maj 202110min
S2-E24.1 - From the Fourth Global NASH Congress -- Changing Paradigms and Guidelines
Send us a text After having time to think, six of the panelists who covered sessions at the Fourth Global NASH Congress get together one more time to consider key takeaways from the Congress. This conversation is organized around changes in treatment paradigms and guidelines. After hearing presentations from 43 speakers at the Fourth Global NASH Congress, six SurfingNASH panelists convene once more to consider how treatment paradigms and guidelines are likely to evolve over the next five ye...
8 Maj 202116min
S2-E24 - Fourth Global NASH Congress -- Wrapping Up
Send us a text The SurfingNASH coverage team from the Fourth Global NASH Congress convenes one more time to consider key takeaways from the Congress. Manal Abdelbalek, Naim Alkhouri, Ian Rowe, Suneil Hosmane, Louise Campbell and Roger Green all share high points, opportunities and lingering questions. On April 28 and 29, 2021, over 175 Fatty Liver stakeholders from across the globe convened virtually for the Fourth Global NASH Congress, and Surfing the NASH Tsunami was there to hear each of ...
6 Maj 202152min
S2-E23.1 - From the Fourth Global NASH Congress -- Diagnosing Diagnostics
Send us a text The SurfingNASH Team has curated over three hours of recordings from the Fourth Global NASH Congress to highlight pieces that discuss the current and future states of diagnostics in Fatty Liver disease. You will hear Manal Abdelmalek, Naim Alkhouri, Suneil Hosmane, Ian Rowe, Jörn Schattenberg, Louise Campbell and Roger Green sharing opinions and debating issues. Discussions about diagnostics ran through SurfingNASH's entire coverage of the Fourth Global NASH Congress. Listen h...
3 Maj 202134min
